Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects

Next Previous
Trial Profile

Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 20 Aug 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Flecainide/modafinil (Primary) ; Modafinil
  • Indications Hypersomnia; Narcolepsy
  • Focus First in man; Proof of concept; Therapeutic Use
  • Sponsors Theranexus

    • Most Recent Events

    • 16 Aug 2019 Results published in the British Journal of Clinical Pharmacology
    • 04 Oct 2016 According to a Theranexus media release, results from this study were recently presented in partnership with the French Armed Forces Biomedical Research Institute (IRBA), during the latest congress held by the European Sleep Research Society (ESRS 2016).
    • 17 May 2016 Results published in a Theranexus media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top